NLM Logo

IMMU-110 MeSH Supplementary Concept Data 2024


MeSH Supplementary
IMMU-110
Unique ID
C505097
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C505097
Registry Number
0
Heading Mapped to
*Doxorubicin
*Immunoconjugates
*Antibodies, Monoclonal, Humanized
Frequency
1
Note
drug immunoconjugate composed of doxorubicin conjugated to the humanized anti-CD74 monoclonal antibody, hLL1, at a doxorubicin/monoclonal antibody ratio of approximately 8:1 (mol/mol); the excellent safety and efficacy profile of IMMU-110 supports clinical testing of this immunoconjugate in the treatment of CD74-positive B-cell malignancies
Source
Clin Cancer Res 2005 Jul 15;11(14):5257-64
Date of Entry
2005/11/03
Revision Date
2019/10/30
IMMU-110 Preferred
page delivered in 0.003s